Product Description
Formula & Concentration
KEPPRA® (levetiracetam) 250 mg, 500 mg, 750 mg, and 1000 mg tablets
KEPPRA® (levetiracetam) 100 mg/mL oral solution
Manufacturer
UCB
Indications
- KEPPRA is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 4 years of age and older with epilepsy.
- KEPPRA is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy.
- KEPPRA is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy.
Shelf Life and Storage
Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature.]